According to Immutep's latest financial reports the company's current revenue (TTM) is -$0.01 M. In 2020 the company made a revenue of $5.75 M an increase over the years 2019 revenue that were of $0.09 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2020 | $5.75 M | 5782.01% |
2019 | $0.09 M | -94.72% |
2018 | $1.85 M | |
2016 | $0.12 M | |
2012 | $1.57 M | |
2010 | $0.53 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Illumina ILMN | $4.65 B | -1,674,820,243.88% | ๐บ๐ธ USA |
![]() FibroGen FGEN | $0.25 B | -92,700,459.71% | ๐บ๐ธ USA |
![]() HTG Molecular Diagnostics
HTGM | $8.65 M | -3,113,817.99% | ๐บ๐ธ USA |